Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver

NCT04206254 is registered in ClinicalTrials.gov with Cure&Sure Biotech Co., LTD as lead sponsor.

NCT NCT04206254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04206254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver
Lead sponsor
Cure&Sure Biotech Co., LTD
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 19, 2019
Completion date
August 5, 2023
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer